Identification
Instrument name
SEQUANA MEDICAL
Symbol
SEQUA
ISIN code
BE0974340722
Exchange / Market
Euronext
Trading location
Brussels
Products family
Stocks
Capitalization compartment
Compartment C
ICB
Medical Equipment
Operation
IPO date
Issue type
Initial Public offering
Catégorie
IPO
Price range
EUR 8.50 - EUR 9.0

Company profile

Sequana Medical is a commercial stage company specialized in the development of medical devices for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. In particular, the group offers the alfapump®, a fully implantable, programmable system with CE mark for the management of refractory ascites (chronic accumulation of fluid in the abdomen) due to cirrhosis of the liver, and malignant ascites (with a life expectancy of six months or less). Sequana Medical is also developing alfapump® DSR, a novel and proprietary approach to the treatment of volume overload in heart failure.

Source: Cofisem - Last Update: 10 Jun 2020
Key Executives
Chief Executive Officer Ian Crosbie
Chief Commercial Officer Martijn Blom
Chief Financial Officer Kirsten Van Bockstaele
Investor Relations Director Lies Vanneste
Source: Cofisem - Last Update: 09 Jun 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Net sales 971 1,029 1,304 1,489 1,685
Income from ordinary activities 971 1,029 1,304 1,489 1,685
Operating income -13,964 -13,077 -7,418 -13,945 -11,356
Cost (net) of financial indebtedness -771 -922 -635 -187 -84
Equity-accounted companies' contribution to results
Net profit from discontinued activities
Net income -14,977 -13,983 -8,225 -13,975 -11,557
Net income (Group share) -14,977 -13,983 -8,225 -13,975 -11,557
Fiscal year end 12.19 12.18 12.17 12.16 12.15
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 10 Jun 2020
Shareholder information
NeoMed 33.30 %
Free float 18.39 %
LSP Health Economics Fund Management B.V. 12.20 %
PMV 9.70 %
FPIM 8.80 %
Newton Biocapital 8.70 %
Capricorn Health-Tech Fund NV 4.70 %
Venture Incubator AG 4.20 %
Source: Cofisem - Last Update: 09 Jun 2020